Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.6B | 1.8B | 1.7B | 1.6B |
Cost of revenue | 1.2B | 1.4B | 1.3B | 1.2B |
Gross profit | 355M | 449M | 414M | 395M |
Operating expense | ||||
Research & development | 127M | 121M | 130M | 121M |
Selling general and admin | 77M | 67M | 98M | 114M |
Other operating expenses | — | — | — | — |
Operating income | 151M | 235M | 186M | 160M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 30M | -937M | -6M | -9M |
Pretax income | 195M | -687M | 195M | 167M |
Tax provision | -16M | 42M | 17M | 12M |
Net income | 211M | -729M | 178M | 155M |
Basic EPS | 0.4 | -1.3 | 0.3 | 0.3 |
Diluted EPS | 0.4 | -1.3 | 0.3 | 0.3 |
Basic average shares | 554M | 553M | 552M | 554M |
Diluted average shares | 557M | 553M | 555M | 557M |
EBITDA | 503M | 839M | 583M | 567M |
Net income from continuing op. | 211M | -729M | 178M | 155M |
Minority interests | -1M | -1M | -1M | 0 |
Preferred stock dividends | — | — | — | — |